SightfileU.S. market data from official filings

Companies › TELA

Tela Bio Inc (TELA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001561921 · EDGAR filings · Updated 2026-07-17

Tela Bio Inc (TELA) has reported institutional ownership of 60.1%, with 36 institutional managers holding positions valued at $16.7M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Institutional ownership
60.1%
Institutional managers
36
Reported 13F value
$16.7M
Insider activity
33 trans.
$4.00M net buying
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Tela Bio Inc has 36 institutional holders and institutional ownership of 60.1%.

Insider activity

Insiders reported 33 transactions (1 buys, 0 sells) across 15 reporting insiders, with a net reported value of $4.00M.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-03-20 (recurring since 2026-03-20) — source filing. The authoritative details are those stated in the filing itself.

Related companies

AURORA CANNABIS INC NO PAR (ACB) · POLARYX THERAPEUTICS INC (PLYX) · TUHURA BIOSCIENCES INC (HURA) · XILIO THERAPEUTICS INC (XLO) · TALPHERA INC (TLPH) · Cognition Therapeutics Inc (CGTX)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.